Inherited thrombophilia and pregnancy: The obstetric perspective

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue SUPPL. 1, 1998, Pages 49-53

  Bonnar, John ^a   Green, Richard ^a   Norris, Lucy ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Fetal loss; Pregnancy; Thrombophilia; Thrombosis

Indexed keywords

HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; CESAREAN SECTION; FEMALE; FETUS WASTAGE; GENETIC SUSCEPTIBILITY; HEPARINIZATION; HUMAN; IMMOBILIZATION; MATERNAL AGE; OBESITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

ANTICOAGULANTS; FEMALE; FETAL DEATH; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; THROMBOPHILIA;

EID: 0031765181     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia; Part 1. Thromb Haemostas 1996;76:651-662
2. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V association with resistance to activated protein C. Nature 1994;369:64-67
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:36983703
4. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the 5,10-methylene tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41
5. Rosendaal FR. Risk factors for venous thrombosis: Prevalence risk and interaction. Semin Haematol 1997;34:171-187
6. Walker ID. Inherited coagulation disorders and thrombophilia and pregnancy. In: Bonnar J, ed. Recent Advances in Obstetrics and Gynaecology. London: Churchill Livingstone 1998; 20:35-64
7. Department of Health and Social Security. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom ( 1991-1993). London: Her Majesty's Stationery Office; 1996
8. Bonnar J. Hypercoagulable states and pregnancy. In: Seghatchian MJ, Samama MM, Hecker SP, eds. Hypercoagulable States, Fundamental Aspects, Acquired Disorders and Congenital Thrombophilia. Boca Raton, FL: CRC Press; 1996:253-257
9. Conard J, Horellou MH, van Dreden P, Lecompte T, Samama MM. Thrombosis and pregnancy in congenital deficiencies of antithrombin III, protein C or protein S: Study of 78 women. Thromb Haemostas 1990;63:319-320
10. De Stefano V, Leone G, Masterangelo S, et al. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C - protein S. Thromb Haemostas 1994;71:799-800
11. Hough RE, Makris M, Preston FE. Pregnancy in women with thrombophilia: Incidence of thrombosis and pregnancy outcome. Br J Haematol 1996;93(Suppl 2): 136 (Abst.)
12. Pabinger I, Schneider B. Gesellschaft für Thrombose-und Haemostase forschung (GTH) Study Group on Natural Inhibitors. Thrombotic risk in hereditary antithrombin III, protein C and protein S deficiency. Arterioscl Thromb Vase Biol 1996; 16:742-748
13. Hellgren M, Svensson P, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995:173:210-213
14. Bokarewa MI, Bremme K, Blombäck M. Arg 506 to Gin mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996;92:473-478
15. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemostas 1997:78:1183-1188
16. Nelson-Piercy C. Hazards of heparin: Allergy, heparin-induced thrombocytopenia and osteoporosis. Ballières Clin Obstet Gynaecol 1997;! 1:2261-2266
17. Food and Drug Administration (FDA). Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture. 15th Dec 1997
18. Sheppard BL, Bonnar J. An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 198U88: 695-705
19. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia: European Prospective Cohort on Thrombophilia (EPCOT). Lancet 1996;348:913-916
20. Brenner B, Madel H, Lanir N, et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997;97:551-554
21. Lindoff C, Ingemarsson I, Martinsson G, et al. Pre-eclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997; 176:457-460